Receptors for insulin-like growth factor II in the rat uterus: Characterization and variation throughout the estrus cycle

Y. Chandrasekhar, S. Narayan, Pomila Singh, M. Nagamani

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

This study was undertaken to identify uterine insulin-like growth factor II receptors and examine the regulation of these receptor levels throughout the estrus cycle. We have demonstrated IGF-II receptors in crude uterine membranes by binding and cross-linking experiments. IGF-II binding to the rat uterine membranes displayed time and temperature dependence and maximum binding was achieved by 2 h at 22Γ. Uterine IGF-II binding sites were specific for binding IGF-II peptide and demonstrated negligible binding affinity for IGF-I and no affinity for insulin. The specific anti-IGF-II receptor antibody, R-II-PAB1, blocked the specific [125I]IGF-II binding to uterine membranes in a dose-dependent manner. The characteristics of uterine IGF-lI receptor are similar to those reported for other tissues, with a single class of high-affinity binding sites with an apparent dissociation constant of l.2 ± 0.5 nmol/l and βmax of 2.65 ± 0.41 pmol/mg protein. Affinity cross-linking experiments indicated that the specific binding of [1251]IGF-II in the uterus is associated with a single band of protein with a mol wt of 250 kD. In mature cycling rats, the proestrus uterus had the lowest level of [125I]IGF-II binding per mg membrane protein, without changes in receptor affinity. However, because of greater yield of protein from proestrus uteri, the total [125I]IGF-II binding capacity of the uterus was similar to the other stages of the estrus cycle. These studies demonstrate the presence of authentic IGF-II receptors in the rat uterus and illustrate variations in the concentration of these receptors in the uterus throughout the estrus cycle.

Original languageEnglish (US)
Pages (from-to)434-441
Number of pages8
JournalActa Endocrinologica
Volume124
Issue number4
StatePublished - 1991

Fingerprint

IGF Type 2 Receptor
Insulin-Like Growth Factor II
Estrus
Uterus
Proestrus
Membranes
Binding Sites
Proteins
rat insulin-like growth factor II
Insulin-Like Growth Factor I
Membrane Proteins
Insulin
Peptides
Temperature
Antibodies

ASJC Scopus subject areas

  • Endocrinology

Cite this

Receptors for insulin-like growth factor II in the rat uterus : Characterization and variation throughout the estrus cycle. / Chandrasekhar, Y.; Narayan, S.; Singh, Pomila; Nagamani, M.

In: Acta Endocrinologica, Vol. 124, No. 4, 1991, p. 434-441.

Research output: Contribution to journalArticle

@article{f00fbb1ef13442618ad6c882444d145f,
title = "Receptors for insulin-like growth factor II in the rat uterus: Characterization and variation throughout the estrus cycle",
abstract = "This study was undertaken to identify uterine insulin-like growth factor II receptors and examine the regulation of these receptor levels throughout the estrus cycle. We have demonstrated IGF-II receptors in crude uterine membranes by binding and cross-linking experiments. IGF-II binding to the rat uterine membranes displayed time and temperature dependence and maximum binding was achieved by 2 h at 22Γ. Uterine IGF-II binding sites were specific for binding IGF-II peptide and demonstrated negligible binding affinity for IGF-I and no affinity for insulin. The specific anti-IGF-II receptor antibody, R-II-PAB1, blocked the specific [125I]IGF-II binding to uterine membranes in a dose-dependent manner. The characteristics of uterine IGF-lI receptor are similar to those reported for other tissues, with a single class of high-affinity binding sites with an apparent dissociation constant of l.2 ± 0.5 nmol/l and βmax of 2.65 ± 0.41 pmol/mg protein. Affinity cross-linking experiments indicated that the specific binding of [1251]IGF-II in the uterus is associated with a single band of protein with a mol wt of 250 kD. In mature cycling rats, the proestrus uterus had the lowest level of [125I]IGF-II binding per mg membrane protein, without changes in receptor affinity. However, because of greater yield of protein from proestrus uteri, the total [125I]IGF-II binding capacity of the uterus was similar to the other stages of the estrus cycle. These studies demonstrate the presence of authentic IGF-II receptors in the rat uterus and illustrate variations in the concentration of these receptors in the uterus throughout the estrus cycle.",
author = "Y. Chandrasekhar and S. Narayan and Pomila Singh and M. Nagamani",
year = "1991",
language = "English (US)",
volume = "124",
pages = "434--441",
journal = "European Journal of Endocrinology",
issn = "0804-4643",
publisher = "BioScientifica Ltd.",
number = "4",

}

TY - JOUR

T1 - Receptors for insulin-like growth factor II in the rat uterus

T2 - Characterization and variation throughout the estrus cycle

AU - Chandrasekhar, Y.

AU - Narayan, S.

AU - Singh, Pomila

AU - Nagamani, M.

PY - 1991

Y1 - 1991

N2 - This study was undertaken to identify uterine insulin-like growth factor II receptors and examine the regulation of these receptor levels throughout the estrus cycle. We have demonstrated IGF-II receptors in crude uterine membranes by binding and cross-linking experiments. IGF-II binding to the rat uterine membranes displayed time and temperature dependence and maximum binding was achieved by 2 h at 22Γ. Uterine IGF-II binding sites were specific for binding IGF-II peptide and demonstrated negligible binding affinity for IGF-I and no affinity for insulin. The specific anti-IGF-II receptor antibody, R-II-PAB1, blocked the specific [125I]IGF-II binding to uterine membranes in a dose-dependent manner. The characteristics of uterine IGF-lI receptor are similar to those reported for other tissues, with a single class of high-affinity binding sites with an apparent dissociation constant of l.2 ± 0.5 nmol/l and βmax of 2.65 ± 0.41 pmol/mg protein. Affinity cross-linking experiments indicated that the specific binding of [1251]IGF-II in the uterus is associated with a single band of protein with a mol wt of 250 kD. In mature cycling rats, the proestrus uterus had the lowest level of [125I]IGF-II binding per mg membrane protein, without changes in receptor affinity. However, because of greater yield of protein from proestrus uteri, the total [125I]IGF-II binding capacity of the uterus was similar to the other stages of the estrus cycle. These studies demonstrate the presence of authentic IGF-II receptors in the rat uterus and illustrate variations in the concentration of these receptors in the uterus throughout the estrus cycle.

AB - This study was undertaken to identify uterine insulin-like growth factor II receptors and examine the regulation of these receptor levels throughout the estrus cycle. We have demonstrated IGF-II receptors in crude uterine membranes by binding and cross-linking experiments. IGF-II binding to the rat uterine membranes displayed time and temperature dependence and maximum binding was achieved by 2 h at 22Γ. Uterine IGF-II binding sites were specific for binding IGF-II peptide and demonstrated negligible binding affinity for IGF-I and no affinity for insulin. The specific anti-IGF-II receptor antibody, R-II-PAB1, blocked the specific [125I]IGF-II binding to uterine membranes in a dose-dependent manner. The characteristics of uterine IGF-lI receptor are similar to those reported for other tissues, with a single class of high-affinity binding sites with an apparent dissociation constant of l.2 ± 0.5 nmol/l and βmax of 2.65 ± 0.41 pmol/mg protein. Affinity cross-linking experiments indicated that the specific binding of [1251]IGF-II in the uterus is associated with a single band of protein with a mol wt of 250 kD. In mature cycling rats, the proestrus uterus had the lowest level of [125I]IGF-II binding per mg membrane protein, without changes in receptor affinity. However, because of greater yield of protein from proestrus uteri, the total [125I]IGF-II binding capacity of the uterus was similar to the other stages of the estrus cycle. These studies demonstrate the presence of authentic IGF-II receptors in the rat uterus and illustrate variations in the concentration of these receptors in the uterus throughout the estrus cycle.

UR - http://www.scopus.com/inward/record.url?scp=0025803511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025803511&partnerID=8YFLogxK

M3 - Article

C2 - 1851592

AN - SCOPUS:0025803511

VL - 124

SP - 434

EP - 441

JO - European Journal of Endocrinology

JF - European Journal of Endocrinology

SN - 0804-4643

IS - 4

ER -